Harmony Biosciences Files 8-K on Shareholder Vote Matters
Ticker: HRMY · Form: 8-K · Filed: May 29, 2024 · CIK: 1802665
| Field | Detail |
|---|---|
| Company | Harmony Biosciences Holdings, INC. (HRMY) |
| Form Type | 8-K |
| Filed Date | May 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: HRMY
TL;DR
Harmony Biosciences held a shareholder vote, details to follow.
AI Summary
Harmony Biosciences Holdings, Inc. filed an 8-K on May 29, 2024, to report on matters submitted to a vote of its security holders. The filing does not detail the specific proposals voted on or the outcomes.
Why It Matters
This filing indicates that Harmony Biosciences held a shareholder meeting where important decisions were made, the details of which will be crucial for understanding the company's future direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain new financial or operational risks.
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Registrant
- May 29, 2024 (date) — Date of report
FAQ
What specific matters were submitted to a vote of Harmony Biosciences' security holders?
The filing does not specify the exact proposals voted on, only that matters were submitted to a vote.
When did the event related to the shareholder vote occur?
The earliest event reported was on May 29, 2024.
What is Harmony Biosciences' principal executive office address?
The address is 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462.
What is Harmony Biosciences' IRS Employer Identification Number?
The IRS number is 82-2279923.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 577 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-05-29 17:01:17
Key Financial Figures
- $0.00001 — ) on which registered Common Stock, $0.00001 par value per share HRMY The Nasdaq
Filing Documents
- hrmy-20240529x8k.htm (8-K) — 48KB
- hrmy-20240529x8k001.jpg (GRAPHIC) — 1KB
- 0001558370-24-008734.txt ( ) — 169KB
- hrmy-20240529.xsd (EX-101.SCH) — 3KB
- hrmy-20240529_lab.xml (EX-101.LAB) — 16KB
- hrmy-20240529_pre.xml (EX-101.PRE) — 10KB
- hrmy-20240529x8k_htm.xml (XML) — 5KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On May 29, 2024, Harmony Biosciences Holdings, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). A total of 40,712,810 shares of the Company's common stock were represented in person or by proxy, constituting a quorum. At the Annual Meeting, stockholders voted on the following two proposals, each of which is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 11, 2024. Proposal 1. The election of three Class I directors listed below to serve until the Company's 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified. Votes For Withheld Broker Non-Votes Jeffrey S. Aronin 18,340,092 11,005,228 11,367,490 R. Mark Graf 18,542,554 10,802,766 11,367,490 Jeffrey M. Dayno, M.D. 20,588,496 8,756,824 11,367,490 Based on the votes set forth above, each of the director nominees was duly elected. Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Abstain 40,204,856 495,232 12,722 Based on the votes set forth above, the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2024, was duly ratified.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HARMONY BIOSCIENCES HOLDINGS, INC. Date: May 29, 2024 By: /s/ Christian Ulrich Christian Ulrich SVP & General Counsel